Amounts recognised in profit or loss
Provision for write-downs of inventories amounted to INR 889.74 lakhs (March 31,2023 - INR 2,087.61 lakhs). These were recognised as an expense during the year and included in changes in value of inventories of work-in-progress, stock-in-trade and finished goods in statement of profit and loss.
Terms/rights attached to equity shares
The company has only one class of equity shares having a par value of ' 2/- per share. Each holder of equity shares is entitled to one vote per share. All equity shares of the Company rank pari passu in all respects including the right to dividend. The company declares and pays dividends in Indian rupees. The dividend proposed by the Board of Directors is subject to the approval of the shareholders in the ensuing Annual General Meeting. During the year ended March 31, 2024, the amount of ' 1.50 per share on the face value of ' 2/- is proposed to the equity shareholders of the Company (Previous year - ' 2.25 per share on face value of ' 2 declared and paid to the equity shareholders of the Company).
In the event of winding-up, subject to the rights of holders of shares issued upon special terms and conditions, the holders of equity shares shall be entitled to receive remaining assets, if any, in proportion to the number of shares held at the time of commencement of winding-up.
The description of the nature and purpose of each reserve within equity as follows :
Capital Reserve :
The Company recognises profit and loss on purchase, sale, issue or cancellation of the Company's own equity instruments to capital reserve.
Securities Premium :
Securities premium reserve is used to record the premium on issue of shares. The reserve is utilised in accordance with the provision of the Companies Act, 2013.
Employee Stock Options Outstanding Account :
The fair value of the equity-settled share based payment transactions with employees is recognised in standalone statement of profit and loss with corresponding credit to Employee Stock Options Outstanding Account.
General Reserve :
The General Reserve is used from time to time to transfer profits from retained earnings for appropriation purposes. As the general reserve is created by a transfer from one component of equity to another and is not an item of other comprehensive income, items included in the general reserve will not be reclassified subsequently to statement of profit and loss.
Retained Earnings :
Retained Earnings are the profits that the Company has earned till date less any transfer to general reserve, dividends or other distributions paid to shareholders.
(i) Information about individual provisions and significant estimates Sales Returns
When a customer has a right to return the product within a given period, the company recognises a provision for returns INR 1,900.60 lakhs as at March 31, 2024 (March 2023 - INR 1,728.18 lakhs). This is measured on the previous history of sales return. Revenue is adjusted for the expected value of the returns and cost of sales & Inventory are adjusted for the value of the corresponding goods to be returned.
Critical judgements in calculating amounts
When a customer has a right to return the product within a given period, the company recognises a provision for sales return INR 1,900.60 lakhs as at March 31,2024 (March 31,2023 - INR 1,728.18 lakhs). This is measured on the previous history of sales return. Revenue is adjusted for the expected value of the returns and cost of sales & Inventory are adjusted for the value of the corresponding goods to be returned.
Additional disclosures as required by Ind AS 115 Disaggregate revenue information
The table below presents disaggregated revenue information from contracts with customers for the year ended March 31, 2024. The company believes that this disaggregation reasonably depicts how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.
Performance obligations
a. Significant payment terms
In case of Domestic Sales, payment terms ranges from 7 days to 90 days based on geography and customers. In case of Export Sales these are either DP at sight, Document against acceptance - 30 days to 120 days, Letters of Credit - 30 days to 120 days.
b. Obligations for returns, refunds and similar obligations
In case of domestic sales, sales return may take place anytime before / after the expiry of goods.
Note 40 : Employee benefit obligations
As required by IND AS 19 'Employee benefits' the disclosures are as under :
(i) Defined benefit plans
a. Leave obligations
The leave obligations cover the company's liability for sick and earned leave.
The amount of the provision of INR 250.68 lakhs (March 31,2023 - INR 297.27 lakhs) is presented as current, since the company does not have an unconditional right to defer settlement for any of these obligations. However, based on past experience, the company does not expect all employees to take the full amount of accrued leave or require payment within the next 12 months and therefore provision is made on the basis of actuarial valuation obtained.
b. Post-employment obligations i. Gratuity
The company provides gratuity for employees in India as per the Payment of Gratuity Act, 1972. Employees who are in continuous service for a period of 5 years are eligible for gratuity. The amount of gratuity payable on retirement/termination is the employees last drawn basic salary per month computed proportionately for 15 days salary multiplied for the number of years of service. The gratuity plan is a funded plan and the company makes contributions to recognized funds in India. The company maintains a target level of funding to be maintained over a period of time based on estimations of expected gratuity payments.
(ii) Defined contribution plans
a. Provident Fund
The company also has certain defined contribution plans. Contributions are made to provident fund in India for employees at the rate of 12% of basic salary as per regulations. The contributions are made to registered provident fund administered by the government. The obligation of the company is limited to the amount contributed and it has no further contractual nor any constructive obligation. The expense recognized during the period towards defined contribution plan is INR 2,535.77 lakhs (March 31,2023 - INR 2,156.39 lakhs).
b. Superannuation
The company contributed INR 131.06 lakhs (March 31, 2023 - INR 115.13 lakhs) to the superannuation plan. The same has been recognized in the Statement of profit and loss account under the head employee benefit expenses.
(iii) Balance sheet amounts - Gratuity
The amounts recognized in the balance sheet and the movements in the net defined benefit obligation over the year are as follows :
The above sensitivity analysis are based on a change in an assumption while holding all other assumptions constant. In practice, this is unlikely to occur, and changes in some of the assumptions may be correlated. When calculating the sensitivity of the defined benefit obligation to significant actuarial assumptions the same method (present value of the defined benefit obligation calculated with the projected unit credit method at the end of the reporting period) has been applied as when calculating the defined benefit liability recognized in the balance sheet.
The methods and types of assumptions used in preparing the sensitivity analysis did not change compared to the prior period.
Fair value hierarchy
Level 1 :Hierarchy includes financial instruments measured using quoted prices. This includes listed equity instruments and mutual funds that have quoted price. The mutual funds are valued using the closing NAV.
Level 2 : The fair value of financial instruments that are not traded in an active market (like forward contract) is determined using valuation techniques which maximise the use of observable market data and rely as little as possible on entity-specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in level 2.
Level 3 : If one or more of the significant inputs is not based on observable market data, the instrument is included in level 3. This is the case for unlisted equity securities etc. included in level 3.
This section explains the judgements and estimates made in determining the fair values of the financial instruments that are (a) recognised and measured at fair value and (b) measured at amortised cost and for which fair values are disclosed in the financial statements. To provide an indication about the reliability of the inputs used in determining fair value, the company has classified its financial instruments into the three levels prescribed under the accounting standard. An explanation of each level follows underneath the table.
Note 43 : Capital Management (a) Risk management
The company aims to manage its capital efficiently so as to safeguard its ability to continue as a going concern and to optimise returns to our shareholders.
The capital structure of the company is based on management's judgement of the appropriate balance of key elements in order to meet its strategic and day-to-day needs. We consider the amount of capital in proportion to risk and manage the capital structure in light of changes in economic conditions and the risk characteristics of the underlying assets. In order to maintain or adjust the capital structure, the company may adjust the amount of dividends paid to shareholders, return capital to shareholders or issue new shares.
The Company's policy is to maintain a stable and strong capital structure with a focus on total equity so as to maintain investor, creditors and market confidence and to sustain future development and growth of its business. The Company will take appropriate steps in order to maintain, or if necessary adjust, its capital structure.
The company monitors capital on the basis of the following gearing ratio : Net debt (total borrowings net of cash and cash equivalents) divided by Total Equity.
Note 44 : Segment Information
(a) Description of segments and principal activities
The company has only one reporting segment of its business i.e. Pharmaceutical, wherein the company's strategic steering committee, consisting of the chief executive officer, the chief financial officer and the manager for corporate planning, examines the group's performance both from a product and geographic perspective.
The steering committee primarily uses a measure of adjusted earnings before other income, finance cost, tax, depreciation and amortisation (EBITDA, see below) to assess the performance of the operating segments. However, the steering committee also receives information about the segment's revenue and assets on a monthly basis.
(b) Adjusted EBITDA
Adjusted EBITDA excludes discontinued operations and the effects of significant items of income and expenditure which may have an impact on the quality of earnings such as restructuring costs, impairments when the impairment is the result of an isolated, non-recurring event. It also excludes the effects of share-based payments and gains or losses on financial instruments.
Interest income and finance cost are not allocated to segments, as this type of activity is driven by the central treasury function, which manages the cash position of the company.
Note 45 : Share Based Payment Plan (ESOP)
A) Employee Stock Option Plan
The Nomination and Remuneration Committee of the Board has approved in the earlier year the grant of equity based incentive scheme under Indoco Remedies Limited Employee Stock Option Plan- 2022. The Company has created Indoco Employees Welfare Trust for implementation of Indoco Remedies Limited Employee Stock Option Plan- 2022.
The options issued under the above scheme vest in a phased manner. During the year 1,03,000 options have been granted by the Company under the above aforesaid Equity based incentive scheme to the employees of the Company.
Note 49 : Additional Regulatory Information
S no. Particulars
1 The Company does not have any Benami property, where any proceeding has been initiated or pending against the Company for holding any Benami property.
2 The Company has not traded or invested in Crypto currency or Virtual Currency during the financial year.
3 The Company does not have any charges or satisfaction which is yet to be registered with ROC beyond the statutory period.
4 The Company has not advanced or loaned or invested funds to any other person(s) or entity(ies), including foreign entities (Intermediaries) with the understanding that the Intermediary shall:
(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (Ultimate Beneficiaries) or
(b) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.
5 The Company has not received any fund from any person(s) or entity(ies), including foreign entities (Funding Party) with the understanding (whether recorded in writing or otherwise) that the Company shall:
(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (Ultimate Beneficiaries) or
(b) provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.
6 The Company has no such transaction which is not recorded in the books of accounts that have been surrendered or disclosed as income during the year in the tax assessments under the Income Tax Act, 1961 (such as, search or survey or any other relevant provisions of the Income Tax Act, 1961).
7 The Company has complied with the number of layers prescribed under clause (87) of section 2 of the Act read with the Companies (Restriction on number of Layers) Rules, 2017.
8 The Company has not given any loans or advances in the nature of loans to the promoters, directors, KMP's and other related parties (as defined under Companies Act 2013) either severely or jointly except for its subsidaries-Warren Remedies Private Limited and FPP Holding Company, LLC.
9 The Company has not been declared as a wilful defaulter by any bank or financial institution or other lenders during the year.
Note 51 : FINANCIAL RISK MANAGEMENT Financial risk management objectives and policies
The Company's financial risk management is an integral part of how to plan and execute its business strategies. The Company's financial risk management policy is set by the Audit Committee of the Board of Director.
Market risk is the risk of loss of future earnings, fair values or future cash flows that may result from a change in the price of a financial instrument. The value of a financial instrument may change as a result of changes in the interest rates, foreign currency exchange rates, equity prices and other market changes that affect market risk sensitive instruments. Market risk is attributable to all market risk sensitive financial instruments including investments and deposits, foreign currency receivables, payables and loans and borrowings.
The Company manages market risk through a Finance department, which evaluates and exercises independent control over the entire process of market risk management. The Finance department recommend the risk management objectives and policies, which are approved by Senior Management and the Audit Committee. The activities of this department include management of cash resources, implementing hedging strategies for foreign currency exposures like foreign exchange forward contracts, borrowing strategies and ensuring compliance with market risk limits and policies.
Market Risk- Interest rate risk
Interest rate risk is the risk that the fair value of future cash flows of the financial instruments will fluctuate because of changes in market interest rates. In order to optimize the Company's position with regards to interest income and interest expenses and to manage the interest rate risk, finance department performs a comprehensive corporate interest rate risk management policy by balancing the proportion of fixed rate and floating rate financial instruments in its total portfolio.
According to the Company interest rate risk exposure is only for floating rate borrowings. For floating rate liabilities, the analysis is prepared assuming the amount of the liability outstanding at the end of the reporting period was outstanding for the whole year. A 50 basis point increase or decrease is used when reporting interest rate risk internally to key management personnel and represents management's assessment of the reasonably possible change in interest rates.
Market Risk- Foreign currency risk.
The company operates internationally and is exposed to foreign exchange risk arising from foreign currency transactions, primarily with respect to USD, EURO, GBP and AUD. Foreign exchange risk arises from future commercial transactions and recognised assets and liabilities denominated in a currency that is not the company's functional currency (INR).
The risk is measured through a forecast of highly probable foreign currency cash flows. The objective of the hedges is to minimise the volatility of the INR cash flows of highly probable forecast transactions.
The company risk management policy is to hedge forecasted foreign currency sales for the subsequent 24 to 60 months. As per the risk management policy, foreign exchange forward contracts are taken to hedge forecasted sales.
The company also imports certain materials and Capital Goods which are denominated in USD, EURO, GBP, CHF, JPY, CNY which exposes the company to foreign currency risk to minimise the risk of imports, the company naturally hedges its imports.
The spot component of forward contracts is determined with reference to relevant spot market exchange rates. The differential between the contracted forward rate and the spot market exchange rate is defined as the forward points.
Credit risk arises from the possibility that the counter party may not be able to settle their obligations as agreed. To manage this, the Company periodically assesses financial reliability of customer and other counter parties, taking into account the financial condition, current economic trends, and analysis of historical bad debts and ageing of financial assets. Individual risk limits are set and periodically reviewed on the basis of such information.
The Company considers the probability of default upon initial recognition of asset and whether there has been a significant increase in credit risk on an ongoing basis through each reporting period. To assess whether there is a significant increase in credit risk the Company compares the risk of default occurring on asset as at the reporting date with the risk of default as at the date of initial recognition. It considers reasonable and supportive forward looking information such as:
• Actual or expected significant adverse changes in business,
• Actual or expected significant changes in the operating results of the counterparty,
• Financial or economic conditions that are expected to cause a significant change to the counterparty's ability to meet its obligations,
• Significant increase in credit risk on other financial instruments of the same counterparty,
• Significant changes in the value of the collateral supporting the obligation or in the quality of the third-party guarantees or credit enhancements.
Financial assets are written off when there is no reasonable expectations of recovery, such as a debtor failing to engage in a repayment plan with the Company. Where loans or receivables have been written off, the Company continues to engage in enforcement activity to attempt to recover the receivable due. Where recoveries are made, these are recognized as income in the statement of Profit and Loss.
The Company measures the expected credit loss of trade receivables and loan from individual customer based on historical trend, industry practices and the business environment in which the entity operates. Loss rates are based on actual credit loss experience and past trends. Based on the historical data, loss on collection of receivable is not material hence no additional provision considered.
Prudent liquidity risk management implies maintaining sufficient cash and marketable securities and the availability of funding through an adequate amount of committed credit facilities to meet obligations when due and to close out market positions. Due to the dynamic nature of the underlying businesses, Company treasury maintains flexibility in funding by maintaining availability under committed credit lines. Management monitor rolling forecasts of the Company's liquidity position (comprising the undrawn borrowing facilities below) and cash and cash equivalents on the basis of expected cash flows.
The bank overdraft facilities may be drawn at any time and may be terminated by the bank without notice. Subject to the continuance of satisfactory credit ratings, the bank loan facilities may be drawn at any time in INR. The amount is arrived at based on the Sanctioned Limits by the Banks and the same is subject to change based on the Maximum Permissible Bank Finance (MPBF) and Drawing Power.
Note 52
on financial statements for the year ended March 31, 2024
Contingent Liabilities not provided for:
(' in lakhs)
|
Particulars
|
As at March 31, 2024
|
As at March 31, 2023
|
A)
|
Matters under dispute
|
|
|
i)
|
Income Tax (? 59.67 lakhs has been paid as pre-deposit Previous year ' 7.63 lakhs)*
|
386.47
|
1,899.29
|
ii)
|
Sales Tax (? 8.02 lakhs has been paid under protest / settlement, Previous year ' 696.52 lakhs) **
|
62.36
|
1034.09
|
iii)
|
Excise / Service Tax (? 79.65 lakhs has been paid as pre-deposit Previous Year ' 82.08 Lakhs)***
|
655.00
|
656.80
|
iv)
|
GST (' 156.99 lakhs has been paid as pre-deposit Previous Year ' 0.45 Lakhs)****
|
3,080.73
|
522.94
|
v)
|
Labour Law Matter
|
50.00
|
50.00
|
B)
|
Bank Guarantees
|
1,269.52
|
485.97
|
C)
|
Letters of Credit
|
2,355.88
|
404.89
|
D)
|
Corporate Guarantee
|
21,450.00
|
-
|
E)
|
Estimated amount of contracts remaining to be executed
|
5,480.15
|
3,856.84
|
Legal Case -
a) MR's / Petitioners have filed a defamation suit against the company under Section 38 / Section 40 of the Specific Relief Act 1963 and the matter is pending before civil court of Jalandhar jurisdiction for ' 5 Lakhs each. Total Contingent liability against the suit is ' 20 Lakhs (Previous Year - ' 20 Lakhs).
b) Chartered of Demand (COD) case filed by Union FMRAI (Federation of Medical and Sales Representatives of India) for revision of field employee's salary which is pending since 2012 in Industrial Tribunal Mumbai in case bearing no. ITR No. 2 of 2012 FMRAI V/s Indoco Remedies Limited, Mumbai. Total Contingent liability against the suit is ' 30 Lakhs (Previous Year - ' 30 Lakhs).
* Income Tax demand comprises of
a) ' 5.98 lakhs (Previous year - ' 5.98 lakhs) appearing as TDS defaults on account of short Deduction / Short Payment & Interest thereon etc. of various assessment years.
b) ' 82.15 lakhs (Previous year - ' 1855.19 lakhs) demand issued by AO on account of Regular Assessment u/s 143(3) for AY 2018-19. The Company has preferred the appeal against the aggrieved demand order before CIT(A) which is yet to be heard. Meanwhile the Company has also applied for rectification u/s 154. The Company received rectification order u/s 154 and tax demand reduced to ' 82.14 Lacs due to correct calculation of book profit u/s 115Jb and allowing MAT credit u/s 115JAA.
c) ' 38.12 lakhs (Previous year - ' 38.12) demand issued by AO on account of proceedings u/s 201(1) / 201(1A) of the Income tax Act for AY 2019-20. The Company has preferred the appeal against the aggrieved demand order before CIT(A) which is yet to be heard.
d) ' 260.22 lakhs (Previous year - ' NIL lakhs) demand issued by AO on account of Regular Assessment u/s 143(3) for AY 2022-23. The Company has preferred the appeal against the aggrieved demand order before CIT(A) which is yet to be heard.
** Sales Tax demand comprises of
(I) Telangana Sales Tax:-
a) ' NIL (Previous year - ' 189.81 lakhs) demand pertaining to classification dispute under Andhra Pradesh VAT Act for the period April 2005 to March 2009. The Company has filed an appeal before High Court which is yet to be heard.
b) ' NIL (Previous year - ' 619.19 lakhs) demand (including penalty) pertaining to classification dispute under Andhra Pradesh VAT Act for the period April 2009 to December 2013. The Company has filed an appeal before Telangana VAT Appellate Tribunal Hyderabad which is yet to be heard.
c) ' NIL (Previous year - ' 96.86 lakhs) is penalty imposed on demand of April 2009 to October 2012 under Andhra Pradesh VAT Act for classification dispute. The Company has filed an appeal before Appellate Deputy Commissioner (CT), Hyderabad Rural Division which is yet to be heard.
d) ' NIL (Previous year - ' 59.88 lakhs) demand pertaining to classification dispute under Telangana VAT Act for the period Jan 2014 to June 2017. The Company has filed an appeal before Appellate Deputy Commissioner (CT), Hyderabad Rural Division which is yet to be heard.
e) ' NIL (Previous year - ' 5.99 lakhs) is penalty imposed on demand pertaining to classification dispute under Telangana VAT Act for the period Jan 2014 to June 2017. The Company has filed an appeal before Deputy Commissioner (CT), Saroornagar Division, Hyderabad which is yet to be heard.
The Company has applied for One Time Settlement (OTS) Scheme 2022 as per the Amnesty Scheme declared by Government of Telangana for the above mentioned disputed Commercial Taxes pending at various forums. As per the Scheme, 50% of balance outstanding taxes will be collected while remaining 50% of demand will be waived off. The Interest & penalty shall be waived off for the dealers availing the scheme. No refunds shall be given under the scheme. As per the Letter of Acceptance of Application of OTS in Form 4, We have paid settlement amount during FY 2022-23. The Final Settlement Order is received and in view of the above settlement payment, pending cases are stated to be withdrawn and arrears are settled as per the Final Settlement Order.
(II) Vijayawada A.P.Sales Tax :-
f) ' 12.83 lakhs (Previous year - ' 12.83 lakhs) in respect of order from Asst. Commissioner (CT) Audit, Vijayawada for classification dispute for the period June 14 to March 2016. The Company has preferred an appeal before Appellate Deputy Commissioner (CT), Vijayawada which was dismissed. The Company preferred appeal to AP VAT Appellate Tribunal Vishakhapatnam which is yet to be heard.
g) ' 3.21 lakhs (Previous year - ' 3.21 lakhs) is penalty imposed on demand pertaining to order from Asst. Commissioner (CT) Audit, Vijaywada for classification dispute for the period June 14 to March 2016. The Company has preferred an appeal before Appellate Deputy Commissioner (CT), Vijaywada which was dismissed. The Company preferred appeal to AP VAT Appellate Tribunal Vishakhapatnam which is yet to be heard.
(III) Goa Sales Tax :-
h) ' 46.32 lakhs (Previous year - ' 46.32 lakhs) as the amount of demand (including penalty) raised by sales tax officer for Financial Year 2007-08,2009-10 and 2013-14 on account of input credit of entry tax. The Company has filed appeal before Asst. Commissioner of Commercial Taxes, who has set aside the previous order and directed Assessing Officer for Re-assessment.
*** Excise tax demand comprises of
a) Company appeal is pending before CESTAT for wrong availment of notification on exempted goods ' 0.66 lakhs (Previous year - ' 0.66 lakhs).
b) Appeal pending before Divisional Dy. Commissioner, Boisar for classification dispute ' 5.04 lakhs (Previous year - ' 5.04 lakhs).
c) CENVAT credit on input service ' NIL lakhs (Previous year - ' NIL lakhs), appeal pending before CESTAT, Mumbai.
d) Company appeal is pending before Divisional Dy. Commissioner, Mumbai for wrong availment of CENVAT credit ' 0.79 lakhs (Previous year - ' 0.79 lakhs).
e) Central excise department is in appeal before Supreme Court for Differential duty on intermixture of vitamins / minerals amounting to ' 2.91 lakhs (Previous year - ' 2.91 lakhs).
f) CENVAT credit on input service ' 494.42 lakhs (Previous year - ' 494.42 lakhs), appeal pending before CESTAT, Mumbai.
g) Company appeal is pending before CESTAT for CENVAT credit availment on physician sample amounting to ' 0.20 lakhs (Previous year - ' 0.20 lakhs).
h) Central excise department is in appeal at Supreme Court for valuation of physician sample ' 11.20 lakhs (Previous year - ' 11.20 lakhs).
i) ' 139.78 lakhs (Previous year - ' 139.78 lakhs) pending before CESTAT, Mumbai for Exempted product-Allopurinol Value Based Duty Reversal.
**** GST demand comprises of
a) The Company received Order under section 73 from Office of the Dy. Comm. of State Tax for tax period 201718 of ' 4.99 lakhs (Previous year - ' 4.99 lakhs). The Company has preferred the appeal against the aggrieved demand order before Appellate Authority which is yet to be heard.
b) The Company received Order from Appellate Authority which is in favour of the Company. The Company has preferred appeal earlier against the Order passed under section 73 from Office of the Additional CT & GST Officer and Cuttack - I City Circle, Cuttack, Odisha for tax period 2020-21 of ' 2.03 lakhs. Pre-deposit of tax against appeal received during the year and demand deleted. Hence, current year demand reduced to ' NIL (Previous Year ' 2.03 lakhs)
c) To regularise the Transitional ITC availed through GSTR-3B, The Company has file Revised Tran-1 Return as per the directions issued by Hon'ble Supreme Court vide Order Dated 22.07.2022 in the matter of Union Bank of India Vs. Filco Trade Centre Pvt.Ltd. SLP (C) No. 32709-32710 / 2018. The Company has received state wise orders in this case for rejection of revise Tran-1 credit. Details are as under:-
The Company is in process of filing appeal in the above mentioned orders at respective state Appellate Authorities against rejection of revised Tran-1 Credit.
d) The Company received Order Dt. October 31, 2023 from the Office of the Jt. Commissioner CGST and Central Excise Mumbai East Commissionerate under section 73(1) of CGST Act, 2017 of ' 631.75 lakhs (' 574.32 lakhs Interest ' 57.43 lakhs) (Previous year - ' NIL) for wrong availment of Tran-1 Credit. The Company has distributed this Tran-1 Credit to its various units registered under different states. The Company has also received adverse order in those states also and demand order was issued by State GST authorities for availment of Tran-1 credit (as mentioned in para c above). Hence this is duplicate addition by Central as well as by State GST authorities for the same issue of availment of Tran-1 credit. The Company has preferred an appeal against the aggrieved demand order before Appellate Authority which is pending.
e) The Company received Order Dt. November 29, 2023 from the Office of the Joint Commissioner, GST & CX, Mumbai East under section 73(1) of CGST Act, 2017 of ' 75.37 lakhs (Interest ' 32.40 lakhs Penalty ' 42.97 lakhs) (Previous year - ' NIL) for the period from July 2018 to January 2019 during which the Company has availed excess ITC as per Order. The Company has preferred an appeal against the aggrieved demand order before Appellate Authority which is pending.
f) The Company received SCN from Office of the Dy.Commissioner of State Tax, Patna, Bihar of ' 2.93 lakhs (Previous year - ' NIL). The assessment is under progress.
g) The Company received Order from Office of the Assistant Commissioner LGSTO 062- Bengaluru, Karnataka of ' 0.75 lakhs (Previous year - ' NIL). The Company has preferred appeal against the aggrieved demand order before Appellate Authority which is pending.
h) The Company received Order from Office of the Deputy Commissioner of State Tax Mumbai Maharashtra
of ' 263.21 lakhs (Previous year - ' NIL) including interest for the year 2018-19. The Company has received
adverse order for the same issue of Tran-1 credit which is mentioned in Para c and Para d above. Hence this is duplicate addition by Central as well as by State GST authorities for the same issue of availment of Tran-1 credit. The Company has preferred an appeal against the aggrieved demand order before Appellate Authority which is pending.
i) The Company received Order from Office of the Dy Commissioner Dehradun Uttarakhand of ' 1.50 lakhs
(Previous year - ' NIL). The Company has preferred an appeal against the aggrieved demand order before
Appellate Authority which is pending.
j) The Company received Order from Office of the Commissioner, Goa of ' 1,584.31 lakhs (Previous year -' NIl). The Company has preferred an appeal against the aggrieved demand order before Appellate Authority which is pending.
(C) (i) Individuals owning and having control of the reporting company
Mr. Suresh G Kare, Mrs. Aruna S Kare, Ms. Aditi Panandikar, Mrs. Madhura S Kare
(ii) Their relatives:
Dr. Milind Panandikar, Mr. Ramnath Kare, Mrs. Sudha Pai, Mrs. Pratima Vaidya, Dr. Mahika Panandikar, Mr. Rohan Ramani, Mr. Megh Panandikar
(D) (i) Key Management Personnel :
Mr. Suresh G Kare, Ms. Aditi Panandikar, Mr. Sundeep V Bambolkar, Mr. Pramod Ghorpade,
Mr. Ramanathan Hariharan
Independent Directors: Mr. Divakar M Gavaskar, Mr. Rajiv P Kakodkar, Dr. (Ms) Vasudha V Kamat, Mr. Abhijit Y Gore
Non Executive Director: Dr. Anand M Nadkarni
(ii) Their Relatives :
Mrs. Aruna S Kare, Mrs. Madhura S Kare
(E) Enterprises controlled by Key Management Personnel
SPA Holdings Pvt. Ltd., Shanteri Investments Pvt. Ltd., Indoco Capital Market Ltd., A.K.Services, Suresh Kare Indoco Foundation, Warren Generics s.r.o.
*Company contribution to Super Annuation Fund which is not considered while calculating the ceiling of Remuneration specified above under Section 198 of the Companies Act, 2013.
** Members have by way of Postal Ballot, on March 7, 2019, passed a Special Resolution approving the payment of remuneration without restriction in case of no profit or inadequate profit.
*** Mr. Suresh G Kare, has ceased to be an Executive Director of the Company w.e.f. June 30, 2023. Hence the Salary of Mr. Suresh G Kare included above is only for the period of April 01, 2023 to June 30, 2023.
*** Shareholders of the Company passed special resolution pursuant to Regulation 17(1A) and 17(1C) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 on June 25, 2023 for re-appointment of Mr. Suresh G Kare as the Chairman of the Company in the capacity of Non-Executive Non-Independent Director w.e.f. July 01, 2023. Consequent to this change in designation from Executive Chairman to Non-Executive Chairman, remuneration to Mr. Suresh G Kare for the period of July 01, 2023 to March 31, 2024 consists only of sitting fees and is based on the number of meetings attended by him during the year.
The above information regarding Micro Enterprises and small Enterprises has been determined on the basis of information available with the Company. No interest has been accrued on delayed payments, if any.
Note 57
Previous year's figures have been regrouped and reclassified wherever necessary.
|